FOXO Technologies Inc. (“FOXO”) today announced the license of two epigenetic clocks, PhenoAge and GrimAge, for use in the prediction of human mortality in the life insurance industry. These licenses, in addition to the Epigenetic Mortality Predictor, give FOXO the exclusive usage of epigenetic clocks developed by Dr. Steve Horvath for the financial services industry.

Quelle: FOXO Technologies Exclusively Licenses Epigenetic Clocks PhenoAge and GrimAge from UCLA